Literature DB >> 10617927

Role of ICAM-1 (CD54) in the development of murine cerebral malaria.

N Favre1, C Da Laperousaz, B Ryffel, N A Weiss, B A Imhof, W Rudin, R Lucas, P F Piguet.   

Abstract

In susceptible mouse strains, infection of mice with Plasmodium berghei ANKA (PbA) results in a lethal complication, cerebral malaria. Cerebral malaria is due to the immune response induced by the parasite, which results in an increased production of TNF, known to increase the expression of adhesion molecules on the endothelia. To investigate the role of the adhesion molecule ICAM-1 (CD54), we infected wild-type (+/+) and ICAM-1-deficient (-/-) mice with PbA. While +/+ mice died 6-8 days after infection, -/- mice survived > 15 days. Parasitaemia was similar in +/+ and -/- mice. Serum TNF concentration was increased by the infection and was significantly higher in infected +/+ than in -/- mice. However, TNF mRNA levels in spleen, lungs, and brain were elevated in both infected +/+ and -/- mice. For IFN-gamma, serum levels were similar in both groups. A breakdown of the blood-brain barrier was evident in infected +/+ mice only. Interestingly, thrombocytopenia was profound in infected +/+, but practically absent in -/- mice. Moreover, macrophage sequestration was evident in brain venules and lung capillaries of +/+ mice and was significantly less important in the alveolar capillaries of infected -/- mice. In contrast, neutrophil sequestration in the lung was similar in both +/+ and -/- mice. Sequestration of parasitized red blood cells was significantly greater in the alveolar capillaries from +/+ than -/- mice. These results indicate that while the immune response is similar in both +/+ and ICAM-1(-/-) mice, the absence of mortality in ICAM(-/-) mice correlates with a decrease of macrophage and parasitized RBC trapping and a less severe thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10617927     DOI: 10.1016/s1286-4579(99)80513-9

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  59 in total

1.  Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.

Authors:  H C van der Heyde; P Bauer; G Sun; W L Chang; L Yin; J Fuseler; D N Granger
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 2.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.

Authors:  Peter D Crompton; Jacqueline Moebius; Silvia Portugal; Michael Waisberg; Geoffrey Hart; Lindsey S Garver; Louis H Miller; Carolina Barillas-Mury; Susan K Pierce
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

3.  Erythropoietin protects against murine cerebral malaria through actions on host cellular immunity.

Authors:  Xu Wei; Ying Li; Xiaodan Sun; Xiaotong Zhu; Yonghui Feng; Jun Liu; Yongjun Jiang; Hong Shang; Liwang Cui; Yaming Cao
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

4.  ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelination.

Authors:  Kristen M Drescher; Laurie J Zoecklein; Moses Rodriguez
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

5.  Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice.

Authors:  P F Piguet; C Da Laperrousaz; C Vesin; F Tacchini-Cottier; G Senaldi; G E Grau
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria.

Authors:  Adriana A Marin; Oscar Murillo; Rodrigo A Sussmann; Luana S Ortolan; Daniella S Battagello; Thatyane de Castro Quirino; Jackson C Bittencourt; Sabrina Epiphanio; Alejandro M Katzin; Leonardo J M Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191

7.  Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.

Authors:  Sylvie Briquet; Nadou Lawson-Hogban; Bertrand Boisson; Miguel P Soares; Roger Péronet; Leanna Smith; Robert Ménard; Michel Huerre; Salah Mécheri; Catherine Vaquero
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

8.  Experimental cerebral malaria develops independently of endothelial expression of intercellular adhesion molecule-1 (icam-1).

Authors:  Theresa N Ramos; Daniel C Bullard; Meghan M Darley; Kristin McDonald; David F Crawford; Scott R Barnum
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

9.  Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response.

Authors:  Xiyue He; Juan Yan; Xiaotong Zhu; Qinghui Wang; Wei Pang; Zanmei Qi; Meilian Wang; Enjie Luo; Daniel M Parker; Margherita T Cantorna; Liwang Cui; Yaming Cao
Journal:  J Immunol       Date:  2014-06-25       Impact factor: 5.422

10.  Murine cerebral malaria development is independent of toll-like receptor signaling.

Authors:  Dieudonnée Togbe; Louis Schofield; Georges E Grau; Bruno Schnyder; Victorine Boissay; Sabine Charron; Stéphanie Rose; Bruce Beutler; Valérie F J Quesniaux; Bernhard Ryffel
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.